Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: BIOCON BIOLOGICS CANADA INC
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Marketed | 02502380 | BIOCON BIOLOGICS CANADA INC | HULIO | Human | Yes | SCHEDULE D | 1 | ADALIMUMAB | 20 MG / 0.4 ML |
| Marketed | 02502380 | BIOCON BIOLOGICS CANADA INC | HULIO | Human | Yes | PRESCRIPTION | 1 | ADALIMUMAB | 20 MG / 0.4 ML |
| Marketed | 02502399 | BIOCON BIOLOGICS CANADA INC | HULIO | Human | Yes | SCHEDULE D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
| Marketed | 02502399 | BIOCON BIOLOGICS CANADA INC | HULIO | Human | Yes | PRESCRIPTION | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
| Marketed | 02502402 | BIOCON BIOLOGICS CANADA INC | HULIO | Human | Yes | SCHEDULE D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
| Marketed | 02502402 | BIOCON BIOLOGICS CANADA INC | HULIO | Human | Yes | PRESCRIPTION | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
| Marketed | 02520974 | BIOCON BIOLOGICS CANADA INC | KIRSTY | Human | Yes | SCHEDULE D | 1 | INSULIN ASPART | 100 UNIT / ML |
| Approved | 02520982 | BIOCON BIOLOGICS CANADA INC | KIRSTY | Human | Yes | SCHEDULE D | 1 | INSULIN ASPART | 100 UNIT / ML |
| Marketed | 02535858 | BIOCON BIOLOGICS CANADA INC | YESAFILI | Human | Yes | SCHEDULE D | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02535858 | BIOCON BIOLOGICS CANADA INC | YESAFILI | Human | Yes | PRESCRIPTION | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02558238 | BIOCON BIOLOGICS CANADA INC | YESAFILI | Human | Yes | PRESCRIPTION | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02558238 | BIOCON BIOLOGICS CANADA INC | YESAFILI | Human | Yes | SCHEDULE D | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02562081 | BIOCON BIOLOGICS CANADA INC | YESINTEK | Human | Yes | PRESCRIPTION | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
| Marketed | 02562081 | BIOCON BIOLOGICS CANADA INC | YESINTEK | Human | Yes | SCHEDULE D | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
| Marketed | 02562103 | BIOCON BIOLOGICS CANADA INC | YESINTEK | Human | Yes | SCHEDULE D | 1 | USTEKINUMAB | 90 MG / ML |
| Marketed | 02562103 | BIOCON BIOLOGICS CANADA INC | YESINTEK | Human | Yes | PRESCRIPTION | 1 | USTEKINUMAB | 90 MG / ML |
| Approved | 02566478 | BIOCON BIOLOGICS CANADA INC | YESINTEK | Human | Yes | PRESCRIPTION | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
| Approved | 02566478 | BIOCON BIOLOGICS CANADA INC | YESINTEK | Human | Yes | SCHEDULE D | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
| Approved | 02569833 | BIOCON BIOLOGICS CANADA INC | YESINTEK | Human | Yes | PRESCRIPTION | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
| Approved | 02569833 | BIOCON BIOLOGICS CANADA INC | YESINTEK | Human | Yes | SCHEDULE D | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
| Approved | 02569841 | BIOCON BIOLOGICS CANADA INC | YESINTEK | Human | Yes | PRESCRIPTION | 1 | USTEKINUMAB | 90 MG / ML |
| Approved | 02569841 | BIOCON BIOLOGICS CANADA INC | YESINTEK | Human | Yes | SCHEDULE D | 1 | USTEKINUMAB | 90 MG / ML |
| Marketed | 02562111 | BIOCON BIOLOGICS CANADA INC | YESINTEK I.V. | Human | Yes | PRESCRIPTION | 1 | USTEKINUMAB | 5 MG / ML |
| Marketed | 02562111 | BIOCON BIOLOGICS CANADA INC | YESINTEK I.V. | Human | Yes | SCHEDULE D | 1 | USTEKINUMAB | 5 MG / ML |
Application information
Related information
Contact us
Version 4.1.0